Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.51 |
| ▸ | CAPN1 | P07384 | 4/20 | 0.48 |
| ▸ | BDKRB2 | P30411 | 5/20 | 0.45 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | GRB2 | P62993 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29397180 | 1.00 | OPRM1 (0.51) | OPRM1OPRD1CAPN1BDKRB2CTSB | |
| SCHEMBL30184771 | 0.96 | OPRM1 (0.47) | OPRM1OPRD1CAPN1BDKRB2CTSB | |
| SCHEMBL29595585 | 0.96 | OPRM1 (0.47) | OPRM1OPRD1CAPN1BDKRB2CTSB | |
| SCHEMBL31752434 | 0.95 | CAPN1 (0.48) | OPRM1OPRD1CAPN1BDKRB2CTSB | |
| SCHEMBL29760883 | 0.93 | CAPN1 (0.55) | OPRM1OPRD1CAPN1BDKRB2CTSB | |
| SCHEMBL30321101 | 0.92 | CAPN1 (0.46) | OPRM1OPRD1CAPN1BDKRB2CTSB | |
| SCHEMBL30626178 | 0.91 | CAPN1 (0.43) | OPRM1OPRD1CAPN1BDKRB2CTSB | |
| SCHEMBL30139003 | 0.91 | CAPN1 (0.43) | OPRM1OPRD1CAPN1BDKRB2CTSB | |
| SCHEMBL30167004 | 0.90 | CAPN1 (0.46) | OPRM1OPRD1CAPN1BDKRB2CTSB | |
| SCHEMBL29375301 | 0.90 | CAPN1 (0.46) | OPRM1OPRD1CAPN1BDKRB2CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4593864-A1 | METHODS FOR TREATING OBESITY | Zealand Pharma A/S (DK) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024068848-A1 | METHODS FOR TREATING OBESITY | ZEALAND PHARMA A/S (DK) | 2024-04-04 | — | — | WO | disclosed |
| US-20230303640-A1 | EXENDIN-4 PEPTIDE ANALOGS | TXP PHARMA AG (CH) | 2023-09-28 | — | — | US | disclosed |